1. MARKETS
  2. SECTOR : OTHERS
  3. INDUSTRY : OTHERS
  4. CAPSOVISION INC.
CapsoVision Inc. XNAS: CV
Download real time
13.01 -0.87 (-6.27%)
279.30% Gain from 52W Low
58,836
XNAS Volume

XNAS 26 Dec, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert


Insider Trading disclosures for CapsoVision Inc

The latest disclosure was made by David Michael Garcia in CapsoVision Inc where a trade of 165,000 Stock Option (right to buy) done was reported to US exchanges on Nov. 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
David Michael Garcia Sr. VP of Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Nov 2025 165,000 165,000 - - Stock Option (right to buy)
Hui Ying Kuo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2025 2,887 2,887 - - Restricted Stock Unit (RSU)
Michele Harari Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2025 2,887 2,887 - - Restricted Stock Unit (RSU)
Wen-Herng Henry King Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2025 2,887 2,887 - - Restricted Stock Unit (RSU)
Joanne Imperial Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2025 2,887 2,887 - - Restricted Stock Unit (RSU)
Julia S. Gouw Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2025 2,887 2,887 - - Restricted Stock Unit (RSU)
Rebecca Petersen Director of Clinical Affairs 18 Aug 2025 7,507 0 - - Stock Option (right to buy)
Rebecca Petersen Director of Clinical Affairs 18 Aug 2025 17,327 3,694 - - Stock Option (right to buy)
Rebecca Petersen Director of Clinical Affairs 18 Aug 2025 24,834 24,834 - 0.4 9,097 Common Stock
Kang-Huai Johnny Wang Director, See Remarks 03 Jul 2025 11,111 0 - - Series D Preferred Stock
Hui Ying Kuo Director 03 Jul 2025 10,354 10,354 - - Common Stock
Hui Ying Kuo Director 03 Jul 2025 34,482 0 - - Series H Preferred Stock
Wen-Herng Henry King Director 03 Jul 2025 20,710 20,710 - - Common Stock
Wen-Herng Henry King Director 03 Jul 2025 68,966 0 - - Series H Preferred Stock
Kang-Huai Johnny Wang Director, See Remarks 03 Jul 2025 1,407,407 0 - - Series A Preferred Stock
Kang-Huai Johnny Wang Director, See Remarks 03 Jul 2025 35,947 0 - - Series H Preferred Stock
Kang-Huai Johnny Wang Director, See Remarks 03 Jul 2025 33,707 0 - - Series C-1 Preferred Stock
Kang-Huai Johnny Wang Director, See Remarks 03 Jul 2025 446,896 721,732 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters